Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $167B
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Quarter Return
-14.57%
1 Year Return
+24.69%
3 Year Return
+110.21%
5 Year Return
+190.84%
10 Year Return
+479.95%
AUM
$148B
AUM Growth
+$148B
Cap. Flow
+$4.57B
Cap. Flow %
3.09%
Top 10 Hldgs %
25.25%
Holding
2,854
New
163
Increased
984
Reduced
853
Closed
114

Sector Composition

1 Technology 26.45%
2 Healthcare 15.87%
3 Consumer Discretionary 11.68%
4 Communication Services 8.96%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OMER icon
2776
Omeros
OMER
$283M
-140,500 Closed -$844K
ORIC icon
2777
Oric Pharmaceuticals
ORIC
$994M
-60,600 Closed -$324K
ORMP icon
2778
Oramed Pharmaceuticals
ORMP
$90.2M
-85,500 Closed -$740K
PASG icon
2779
Passage Bio
PASG
$22.7M
-59,500 Closed -$184K
PLRX icon
2780
Pliant Therapeutics
PLRX
$101M
-29,800 Closed -$209K
PRLD icon
2781
Prelude Therapeutics
PRLD
$68.5M
-29,700 Closed -$205K
PSNL icon
2782
Personalis
PSNL
$434M
-79,500 Closed -$651K
QNCX icon
2783
Quince Therapeutics
QNCX
$85.9M
-35,800 Closed -$222K
REKR icon
2784
Rekor Systems
REKR
$141M
-83,200 Closed -$379K
RSKD icon
2785
Riskified
RSKD
$748M
-53,000 Closed -$320K
SGHT icon
2786
Sight Sciences
SGHT
$213M
-28,000 Closed -$324K
SKYT icon
2787
SkyWater Technology
SKYT
$578M
-21,500 Closed -$233K
SPIR icon
2788
Spire Global
SPIR
$281M
-103,000 Closed -$216K
SPRU icon
2789
Spruce Power Holding Corp
SPRU
$25.9M
-247,300 Closed -$492K
STRO icon
2790
Sutro Biopharma
STRO
$72.7M
-76,600 Closed -$630K
STTK icon
2791
Shattuck Labs
STTK
$47M
-32,200 Closed -$137K
TCRT icon
2792
Alaunos Therapeutics
TCRT
$4.21M
-511,120 Closed -$333K
TSHA icon
2793
Taysha Gene Therapies
TSHA
$797M
-41,000 Closed -$267K
URGN icon
2794
UroGen Pharma
URGN
$900M
-47,900 Closed -$417K
VKTX icon
2795
Viking Therapeutics
VKTX
$3.04B
-166,500 Closed -$500K
VRM icon
2796
Vroom, Inc. Common Stock
VRM
$148M
-161,900 Closed -$431K
WPRT
2797
Westport Fuel Systems
WPRT
$48.4M
-345,500 Closed -$555K
ZG icon
2798
Zillow
ZG
$19.7B
-265,869 Closed -$12.8M
ZYME icon
2799
Zymeworks
ZYME
$1.12B
-118,500 Closed -$776K
ZYXI icon
2800
Zynex
ZYXI
$49.7M
-54,310 Closed -$338K